Creon and Zanaflex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Creon (pancrelipase (amylase;lipase;protease)) and Zanaflex (tizanidine hydrochloride). Common drug interactions include urinary tract infection among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Creon and Zanaflex. It is created by eHealthMe based on reports of 83 people who take the same drugs from the FDA, and is updated regularly.

What is Creon?

Creon has active ingredients of pancrelipase (amylase;lipase;protease). It is often used in pancreatitis. eHealthMe is studying from 29,489 Creon users. Check the latest studies of Creon.

What is Zanaflex?

Zanaflex has active ingredients of tizanidine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 17,476 Zanaflex users. Check the latest studies of Zanaflex.



On Aug, 04, 2026

83 people who take Creon and Zanaflex together, and have interactions are studied.

Creon and Zanaflex drug interactions.

What are the common drug interactions of Creon and Zanaflex, by gender? *:

female:

  1. Urinary tract infection
  2. Fatigue (feeling of tiredness)
  3. Weight decreased
  4. Asthenia (weakness)
  5. Diarrhoea
  6. Fall
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Pneumonia
  9. Headache (pain in head)
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

male:

  1. Anxiety
  2. Disability
  3. Nausea (feeling of having an urge to vomit)
  4. Pancreatitis relapsing
  5. Dyspepsia (indigestion)
  6. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  7. Abdominal pain
  8. Cataract (clouding of the lens inside the eye)
  9. Death
  10. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)

What are the common drug interactions of Creon and Zanaflex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal distension
  2. Colonic obstruction (obstruction in colon)
  3. Dry skin
  4. Gingivitis (inflammation of gums)
  5. Headache (pain in head)
  6. Oral herpes (viral infection of mouth)
  7. Rash
  8. Volvulus (obstruction caused by twisting of the stomach or intestine)
  9. Death
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

40-49:

  1. Dizziness
  2. Hepatic steatosis (fatty liver disease)
  3. Syncope (loss of consciousness with an inability to maintain postural tone)
  4. Abdominal pain
  5. Chest pain
  6. Diarrhoea
  7. Nausea (feeling of having an urge to vomit)
  8. Anxiety
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)

50-59:

  1. Arthralgia (joint pain)
  2. Back pain
  3. Depression
  4. Diarrhoea
  5. Gait disturbance
  6. Headache (pain in head)
  7. Insomnia (sleeplessness)
  8. Neck pain
  9. Neuropathy peripheral (surface nerve damage)
  10. Pain in extremity

60+:

  1. Urinary tract infection
  2. Asthenia (weakness)
  3. Herpes zoster
  4. Infusion site bruising
  5. Infusion site swelling
  6. Neoplasm malignant (cancer tumour)
  7. Pancreatic carcinoma (pancreatic cancer)
  8. Anaesthetic complication
  9. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  10. Blood pressure decreased

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 21 people, 25.30%
  2. Pain: 17 people, 20.48%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 15 people, 18.07%
  4. Fibromyalgia (a long-term condition which causes pain all over the body): 14 people, 16.87%
  5. Immunodeficiency Common Variable: 12 people, 14.46%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 12.05%
  7. Stress And Anxiety: 8 people, 9.64%
  8. Nausea (feeling of having an urge to vomit): 8 people, 9.64%
  9. Insomnia (sleeplessness): 8 people, 9.64%
  10. Constipation: 8 people, 9.64%

* Approximation only. Some reports may have incomplete information.

Do you take Creon and Zanaflex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Creon and Zanaflex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Creon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zanaflex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Creon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zanaflex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pancrelipase (amylase;lipase;protease) and tizanidine hydrochloride (the active ingredients of Creon and Zanaflex, respectively), and Creon and Zanaflex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: